HRMY vs RNA
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 23, 2026
HRMY
RNA
Investment Advisor Scores
RNA
AI Analyst Insights
Detailed Metrics Comparison
| Metric | HRMY | RNA | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.0604 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 30.3% | -21.9% | HRMY |
| Earnings Growth | 88.2% | 0.0% | HRMY |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.2/100 | 48.7/100 | HRMY |
| Profit Margin | 18.9% | -184.1% | HRMY |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
HRMY
NeutralMixed signals - no dominant trend phase, RSI 36
RNA
MarkdownPrice below a falling SMA50 (slope -12.9%), weak momentum, RSI 42
Fundamentals Snapshot
| Metric | HRMY | RNA |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 5.2 | -1.4 |
| Trailing P/E | 11.6 | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | -0.2% |
| Gross Margin | 0.8% | -0.6% |
| Operating Margin | 0.3% | -7.5% |
| EPS | 3.10 | -5.44 |
| Dividend Yield | — | — |